People · Operator
Named in public records as an officer, director or promoter · active 2023–2026 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VitaNav Inc. | — | Other | Series A | $10.7M | $3.3M | 2023 |
| Paterna BioSciences HoldCo Inc. | — | Biotechnology | Seed | $2.1M | $11.4M | 2023 |
| Sethera Therapeutics, Inc | — | Biotechnology | Seed | $1.9M | $8.0M | 2024 |
Cynthia Tsai at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cynthia Tsai on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yakov Kogan | 1 | 2 |
| James Hotaling | 1 | 2 |
| Edward Rowland | 1 | 2 |
| Danny Mitchell | 1 | 2 |
| Deirdre Conway | 1 | 2 |
| Clifford Morgan | 1 | 1 |
| Vahe Bandarian | 1 | 1 |
| Karsten Eastman | 1 | 1 |
| Ryan Morley | 1 | 1 |
| Price Devon | 1 | 1 |
| Eduardo Brondi | 1 | 1 |
| Albert Baladi | 1 | 1 |
| Peter Bayne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.